Tekla Capital Management LLC Bausch Health Companies Inc. Transaction History

Tekla Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$21.37 - $34.38 $2.17 Million - $3.49 Million	-101,412 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$15.31 - $21.12 $260,270 - $359,040	-17,000 Reduced 14.36%	101,412 $2.11 Million
Q1 2020 May 14, 2020	SELL	$12.98 - $30.25 $264,792 - $617,100	-20,400 Reduced 14.7%	118,412 $1.84 Million
Q4 2019 Feb 13, 2020	SELL	$18.89 - $31.89 $566,700 - $956,700	-30,000 Reduced 17.77%	138,812 $4.15 Million
Q1 2019 May 14, 2019	SELL	$20.23 - $26.29 $469,093 - $609,612	-23,188 Reduced 12.08%	168,812 $4.17 Million
Q3 2018 Nov 13, 2018	BUY	$20.64 - $25.67 $3.96 Million - $4.93 Million	192,000 New	192,000 $4.93 Million

255

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.07B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tekla Capital Management LLC with notifications on news.